Is the Initial Treatment in Stage IB2 Cervical Carcinoma Neoadjuvant Chemothreapy or Primary Surgery?

• Päätekijät: Taner Turan (Tekijä), Derya Akdağ (Tekijä), Nurettin Boran (Tekijä), Nuray Yüksel (Tekijä), Gökhan Tulunay (Tekijä), Nejat Özgül (Tekijä), Faruk Köse (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Medical Network, 2009-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

OBJECTIVE: It is expected that neoadjuvant chemotherapy (NACT) decrease tumor size, increase the operability and improve surgical-pathologic risk factors so that improve the survival. In this study we evaluated the effect of NACT on surgical-pathologic risk factors and survival. STUDY DESIGN: Betwee...